Multi-omic cancer subtype clustering with random-walk-refined cross-view contrastive learning

Cancer heterogeneity complicates precision oncology, and robust multi-omic subtyping remains challenging. Existing contrastive integration methods often force heterogeneous omics into a single shared latent space and treat all non-matching samples as negatives, which can suppress modality-specific structure and separate biologically similar patients. We present Subtype-DIVIDE, a self-supervised multi-view contrastive framework for integrative cancer subtyping. The model encodes each omic modality separately and performs target-conditioned cross-view alignment, using the target modality’s affinity structure to guide inter-view consistency. To reduce false negatives, Subtype-DIVIDE further refines contrastive supervision with per-omic random-walk soft-positive masks constructed from modality-specific affinity graphs. Across nine TCGA cohorts spanning copy number, DNA methylation, mRNA, and miRNA data, Subtype-DIVIDE achieved statistically significant survival separation in all datasets and the highest mean number of clinically enriched variables among the compared methods. Cox models, leave-one-cluster-out analyses, and technical covariate tests supported the clinical relevance and robustness of the inferred subtypes. Ablation studies showed that cross-view alignment is essential, while diffusion-based soft positives improved robustness. A KIRC case study identified coherent subtype programs involving metabolism, vascular and inflammatory signaling, extracellular-matrix remodeling, and epithelial transport. External validation on two independent cohorts, performed without hyperparameter retuning, supported the generalizability of the inferred subtypes. In 222 CPTAC-3 clear-cell renal carcinoma cases, the subtypes were significantly associated with pathologic stage and T category across all training repeats and recapitulated the KIRC subtype programs. In 1,980 METABRIC breast tumors, they consistently showed significant survival separation and enrichment for age, nodal status, and stage across all repeats.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-10-31
DOI
https://doi.org/10.1038/s41598-026-77559-6
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-omic cancer subtype clustering with random-walk-refined cross-view contrastive learning

Xian Mallory, Zefeng Li, Liting Zhang
Scientific Reports
Bioinformatics and Genomic Networks
article

Multi-omic cancer subtype clustering with random-walk-refined cross-view contrastive learning

Xian Mallory, Zefeng Li, Liting Zhang
article en

Abstract

Cancer heterogeneity complicates precision oncology, and robust multi-omic subtyping remains challenging. Existing contrastive integration methods often force heterogeneous omics into a single shared latent space and treat all non-matching samples as negatives, which can suppress modality-specific structure and separate biologically similar patients. We present Subtype-DIVIDE, a self-supervised multi-view contrastive framework for integrative cancer subtyping. The model encodes each omic modality separately and performs target-conditioned cross-view alignment, using the target modality’s affinity structure to guide inter-view consistency. To reduce false negatives, Subtype-DIVIDE further refines contrastive supervision with per-omic random-walk soft-positive masks constructed from modality-specific affinity graphs. Across nine TCGA cohorts spanning copy number, DNA methylation, mRNA, and miRNA data, Subtype-DIVIDE achieved statistically significant survival separation in all datasets and the highest mean number of clinically enriched variables among the compared methods. Cox models, leave-one-cluster-out analyses, and technical covariate tests supported the clinical relevance and robustness of the inferred subtypes. Ablation studies showed that cross-view alignment is essential, while diffusion-based soft positives improved robustness. A KIRC case study identified coherent subtype programs involving metabolism, vascular and inflammatory signaling, extracellular-matrix remodeling, and epithelial transport. External validation on two independent cohorts, performed without hyperparameter retuning, supported the generalizability of the inferred subtypes. In 222 CPTAC-3 clear-cell renal carcinoma cases, the subtypes were significantly associated with pathologic stage and T category across all training repeats and recapitulated the KIRC subtype programs. In 1,980 METABRIC breast tumors, they consistently showed significant survival separation and enrichment for age, nodal status, and stage across all repeats.

Scientific Reports
Florida State University (US), Binghamton University (US), University of West Florida (US)
Openalex Percentile: Top 22%
Bioinformatics and Genomic Networks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon